Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Puma Biotechnology, Inc. Company Profile

08:49 EDT 23rd April 2014 | BioPortfolio

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.

News Articles [246 Associated News Articles listed on BioPortfolio]

Puma Biotechnology nets $130mm in latest public offering

Puma Biotechnology Inc. (in-licenses cancer drug candidates) netted $130mm through the public sale of 1.1mm shares (including the overallotment) at $122.50.

BioNotebook: IPOs abound as Dicerna, Celladon launch; Puma seeks $115m; Omeros looks to Phase IIb

Already public Puma Biotechnology also plans to take advantage of investor enthusiasm for biotechnology stocks. The Los Angeles-based company filed documents with the US Securities and Exchange Commis...

Puma Biotechnology releases positive Phase II results of breast cancer drug

US-based biopharmaceutical firm Puma Biotechnology has released top line results from the I-SPY 2 Trial ('Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecula...

Puma closes public offering financing of $138 million

Puma Biotechnology announced the closing of its public offering financing of 1,126,530 shares of its common stock for gross proceeds of $138 million. Puma Biotechnology closed an underwritten public o...

Healthcare Companies Report Results, Patents, and Stock Movements - Analyst Notes on Puma Biotechnology, Alnylam, INSYS Therapeutics, Peregrine Pharmaceuticals, and VIVUS

NEW YORK, April 10, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Puma Biotechnology, Inc. (NYSE: PBYI), Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), INSYS Th...

Puma Biotechnology Inc (NYSE:PBYI): Set To Fly High In 2014 With Neratinib

The year 2014 could be a transformative one for Puma Biotechnology Inc (NYSE:PBYI) as neratinib offers potential upside opportunity.[More...]

Puma raises $120 million in follow-on

Puma Biotechnology Inc. (NYSE:PBYI) raised $120 million through the sale of 979,592 shares at $122.50 in a follow-on underwritten by BofA Merrill Lynch; Citigroup; Leerink Partners; Cowen; and UBS Sec...

Is Puma Biotech's High Stock Price Justified?

By Peter Geschek:One of the best performing stocks in 2013 was Puma Biotechnology (PBYI). Puma's shares skyrocketed during the year, climbing over 400 percent from the January 2013 level of $19 to tou...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Korres quercetin 7 oak hydrating antiageing and antiwrinkle [Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.]

Korres Quercetin & Oak Day Cream for Normal to Dry Skin SPF 4

Bio-active anti-aging [S.I.P.R.E.S. SRL]

Bio-Active Anti-Aging Cream Multi-Protection Daily Renewal SPF 15 Advanced Double Lifting Effect

Biodynamic skin [S.I.P.R.E.S. SRL]

Biodynamic Skin Solution

PubMed Articles [386 Associated PubMed Articles listed on BioPortfolio]

Aurora kinase inhibition induces PUMA via NF-kB to kill colon cancer cells.

Aurora kinases play a key role in mitosis and are frequently overexpressed in a variety of tumor cells. Inhibition of aurora kinases results in mitotic arrest and death of cancer cells, and has been e...

The essential role of p53 Upregulated Modulator of Apoptosis and its regulation by FoxO3a transcription factor in β-amyloid induced neuron death.

Neurodegeneration underlies the pathology of Alzheimer disease (AD). The molecules responsible for such neurodegeneration in AD brain are mostly unknown. Recent findings indicate that the BH3-only pro...

Interdependence of Bad and Puma during Ionizing-Radiation-Induced Apoptosis.

Ionizing radiation (IR)-induced DNA double-strand breaks trigger an extensive cellular signaling response that involves the coordination of hundreds of proteins to regulate DNA repair, cell cycle arre...

Development and enhancement of agricultural biotechnology in some countries in Latin America.

A number of research institutions and both local and international agencles in Latin America are using biotechnology as part of an effort to enhance agricultural productivity. However, it is very much...

Editorial: Latest methods and advances in biotechnology.

The latest "Biotech Methods and Advances" special issue of Biotechnology Journal continues the BTJ tradition of featuring the latest breakthroughs in biotechnology. The special issue is edited by our...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors

In the laboratory, Kevetrin activates p53, a tumor suppressor protein that has an important role in protecting the body. p53 functions by activating proteins that repair DNA and kill cells...

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

This study will be a Phase I, randomized, double blind, safety and immunogenicity trial of the Vero cell based 116E neonatal rotavirus vaccine candidate strain in healthy non-malnourished...

Companies [803 Associated Companies listed on BioPortfolio]

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company...


Task Group Public Perceptions of Biotechnology

The Task Group on Public Perceptions of Biotechnology is one of the six Task Groups of the European Federation of Biotechnology. It was established in 1991, to increase public awareness and understand...

Missouri Biotechnology Association

The Missouri Biotechnology Association is focused on maintaining the growth of the biotechnology industry generated by the research and development communities of Missouri. While we have made great st...

Swiss Biotech Association (SBA)

The Swiss Biotech Association (SBA) is the national association representing biotechnology companies, academic institutions, regional biotechnology centres and related organisations throughout Switzer...

More Information about "Puma Biotechnology, Inc." on BioPortfolio

We have published hundreds of Puma Biotechnology, Inc. news stories on BioPortfolio along with dozens of Puma Biotechnology, Inc. Clinical Trials and PubMed Articles about Puma Biotechnology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Puma Biotechnology, Inc. Companies in our database. You can also find out about relevant Puma Biotechnology, Inc. Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record